Van Vliet IM - Search Results

1

Recent advances in the psychopharmacology of social phobia.

Den Boer JA, Van Vliet IM, Westenberg HG. Den Boer JA, et al. Among authors: van vliet im. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul;18(4):625-45. doi: 10.1016/0278-5846(94)90073-6. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7938556 Review.

2

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.

van Vliet IM, den Boer JA, Westenberg HG. van Vliet IM, et al. Eur Neuropsychopharmacol. 1992 Mar;2(1):21-9. doi: 10.1016/0924-977x(92)90032-4. Eur Neuropsychopharmacol. 1992. PMID: 1638170 Clinical Trial.

3

Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.

den Boer JA, Westenberg HG, De Leeuw AS, van Vliet IM. den Boer JA, et al. Among authors: van vliet im. Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:47-52. Int Clin Psychopharmacol. 1995. PMID: 7622824

4

Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).

Slaap BR, van Vliet IM, Westenberg HG, den Boer JA. Slaap BR, et al. Among authors: van vliet im. J Affect Disord. 1995 Jan 11;33(1):31-8. doi: 10.1016/0165-0327(94)00070-p. J Affect Disord. 1995. PMID: 7714306 Clinical Trial.

5

Recent developments in the psychopharmacology of social phobia.

Den Boer JA, van Vliet IM, Westenberg HG. Den Boer JA, et al. Among authors: van vliet im. Eur Arch Psychiatry Clin Neurosci. 1995;244(6):309-16. doi: 10.1007/BF02190409. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7772614 Review.

6

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine.

van Vliet IM, den Boer JA, Westenberg HG. van Vliet IM, et al. Psychopharmacology (Berl). 1994 Jun;115(1-2):128-34. doi: 10.1007/BF02244762. Psychopharmacology (Berl). 1994. PMID: 7862884 Clinical Trial.

7

MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

van Vliet IM, Westenberg HG, Den Boer JA. van Vliet IM, et al. Psychopharmacology (Berl). 1993;112(4):483-9. doi: 10.1007/BF02244898. Psychopharmacology (Berl). 1993. PMID: 7871061 Clinical Trial.

8

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

van Vliet IM, Slaap BR, Westenberg HG, Den Boer JA. van Vliet IM, et al. Eur Neuropsychopharmacol. 1996 May;6(2):103-10. doi: 10.1016/0924-977x(95)00070-6. Eur Neuropsychopharmacol. 1996. PMID: 8791035 Clinical Trial.

9

Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.

Slaap BR, van Vliet IM, Westenberg HG, Den Boer JA. Slaap BR, et al. Among authors: van vliet im. J Affect Disord. 1996 Jun 20;39(1):13-9. doi: 10.1016/0165-0327(96)00013-4. J Affect Disord. 1996. PMID: 8835649 Clinical Trial.

10

A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.

van Vliet IM, den Boer JA, Westenberg HG, Slaap BR. van Vliet IM, et al. J Clin Psychopharmacol. 1996 Aug;16(4):299-306. doi: 10.1097/00004714-199608000-00005. J Clin Psychopharmacol. 1996. PMID: 8835705 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters